FILTER

LATEST INTERVIEWS

Brian Frenzel

PRESIDENT AND CEO, TOSK, INC.
Tosk, Inc. is a small molecule, oncology drug discovery and development company.

Conrad Bucheleres, Wei Hong & Yong Zhang

AZELIS GREATER CHINA
Azelis sources an increasing array of speciality chemicals in China and distributes across the world.

Peter Parker

MANAGING GENERAL PARTNER, BIOINNOVATION CAPITAL AND CO-FOUNDER AND DIRECTOR, LABCENTRAL
LabCental offers life science companies in Massachusetts at an early stage the facilities they need to develop

Abraham Klip Moshinsky

GENERAL DIRECTOR, UNIGEL MEXICO
Unigel Mexico laments the country’s inadequate feedstock production.

Lieven Vander Elstraeten

CEO, BERTSCHI SINGAPORE PTE LTD
Bertschi Singapore will to continue the rapid expansion of its capacity and services on Jurong Island.

David Cory

CEO, EIGER BIOPHARMACEUTICALS
Founded in 2008, Eiger BioPharmaceuticals is a late-stage biopharmaceutical company focused on developing and commercializing targeted therapies for rare diseases.

Barbara Weber

CEO, TANGO THERAPEUTICS
Tango Therapeutics is targeting unaddressed disease mechanisms in cancer to develop transformational new drugs for patients.

Ángel Tobar

GENERAL MANAGER ANDEAN REGION, EPIROC
"Battery-charging technologies should be used in a similar way to cellphones, regardless of the brand"

Eduardo Denyer Angel

PRESIDENT, BRENNTAG LATIN AMERICA NORTH
Brenntag is growing rapidly in Mexico through aquistions and increasing market share and penetration.

Michael Bigham & Evan Loh

PARATEK PHARMACEUTICALS
Paratek focuses on drugs that target infectious disease and other difficult-to-treat conditions.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Peru Mining 2025 Pre-Release II

Featuring insights from nearly 50 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting the country's window of opportunity with the energy transition and copper's critical role.

PARTNER EVENTS